US says breast cancer drug did not extend lives

US says breast cancer drug did not extend lives WASHINGTON – Follow-up studies of a Roche breast cancer drug showed that it failed to extend the lives of patients, federal health scientists said, opening the door for it to be potentially withdrawn for use in treating that disease. Read more on The Kentucky Post

Patients With Irritable Bowel Syndrome Not More Likely To Develop Polyps Or Colon Cancer, U-M Study Says

Patients with irritable bowel syndrome are at no greater risk of having polyps, colon cancer or inflammatory bowel diseases than healthy people undergoing colonoscopies, according to new research published in the American Journal of Gastroenterology. Source: General Cancer News Articles Provided by Cancer Compass

Lawmaker says health care ad distorts and hurts

Lawmaker says health care ad distorts and hurts A Pennsylvania lawmaker whose parents recently died of cancer is among the targets of an ad campaign by a conservative group that questions congressional Democrats’ interest in preventing the disease. Read more on AP via Yahoo! Finance

Kidney cancer drug too expensive, says Nice

Kidney cancer drug too expensive, says Nice A drug to treat advanced kidney cancer has been rejected for NHS use by the National Institute for Health and Clinical Excellence. Read more on Channel 4

Women should undergo fewer Pap tests for cervical cancer, medical group says

Just days after the release of controversial new guidelines recommending against routine mammograms for most women under 50, a different group of medical professionals has announced that the frequency of Pap tests for cervical cancer detection should also be decreased for most women. [More]

[...]